STOCK TITAN

MIMEDX to Host Second Quarter 2025 Operating and Financial Results Conference Call on July 30

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences earnings

MIMEDX (NASDAQ: MDXG) has scheduled its second quarter 2025 earnings conference call for July 30, 2025. The company will release its Q2 2025 operating and financial results after market close, followed by a management-hosted webcast and conference call at 4:30 p.m. Eastern Time.

Investors can access the call through the webcast or by phone using dedicated U.S. (877-407-6184) and international (201-389-0877) numbers with conference ID 13754722. A replay will be available on the company's website for approximately 30 days after the event.

Loading...
Loading translation...

Positive

  • None.

Negative

  • None.

News Market Reaction 1 Alert

+6.00% News Effect

On the day this news was published, MDXG gained 6.00%, reflecting a notable positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

MARIETTA, Ga., July 16, 2025 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”) today announced that it will report its operating and financial results for the second quarter ended June 30, 2025 after the market close on Wednesday, July 30, 2025. The MIMEDX senior management team will host a webcast and conference call to review its results beginning at 4:30 p.m. Eastern Time on the same day.

The conference call can be accessed using the following information:

Webcast: Click here
U.S. Investors: 877-407-6184
International Investors: 201-389-0877
Conference ID: 13754722

A replay of the webcast will be available for approximately 30 days on the Company’s website at www.mimedx.com following the conclusion of the event.

About MIMEDX
MIMEDX is a pioneer and leader focused on helping humans heal. With more than a decade of helping clinicians manage chronic and other hard-to-heal wounds, MIMEDX is dedicated to providing a leading portfolio of products for applications in the wound care, burn, and surgical sectors of healthcare. The Company’s vision is to be the leading global provider of healing solutions through relentless innovation to restore quality of life. For additional information, please visit www.mimedx.com.

Contact:
Matt Notarianni
Investor Relations
470-304-7291
mnotarianni@mimedx.com


FAQ

When will MIMEDX (MDXG) report Q2 2025 earnings?

MIMEDX will report Q2 2025 earnings after market close on Wednesday, July 30, 2025, followed by a conference call at 4:30 p.m. Eastern Time.

How can investors access MIMEDX's Q2 2025 earnings call?

Investors can access the call via webcast or by phone: U.S. investors can call 877-407-6184, international investors can call 201-389-0877, using Conference ID 13754722.

Will there be a replay available of MIMEDX's Q2 2025 earnings call?

Yes, a replay of the webcast will be available for approximately 30 days on MIMEDX's website (www.mimedx.com) following the event.

What time is MIMEDX's Q2 2025 earnings conference call?

MIMEDX's Q2 2025 earnings conference call is scheduled for 4:30 p.m. Eastern Time on Wednesday, July 30, 2025.
Mimedx Group Inc

NASDAQ:MDXG

MDXG Rankings

MDXG Latest News

MDXG Latest SEC Filings

MDXG Stock Data

1.07B
145.45M
1.7%
71.51%
3.36%
Biotechnology
Surgical & Medical Instruments & Apparatus
Link
United States
MARIETTA